CHAKKA-PASTKI JAG‘ BO‘G‘IMI DISFUNKSIYASIDA NEVROLOGIK VA PSIXOEMOTSIONAL BUZILISHLARNI KOMPLEKS TASHXISLASH HAMDA NEVROLOGIK YONDASHUV ASOSIDA DAVOLASHNI TAKOMILLASHTIRISH
##article.subject##:
chakka-pastki jag‘ bo‘g‘imi disfunksiyasi, nevrologik buzilishlar, kuchlanish tipidagi sefalgiya, psixoemotsional holat, vegetativ disfunksiya, kompleks davolash, nevrologik yondashuv##article.abstract##
Ushbu tadqiqotda chakka-pastki jag‘ bo‘g‘imi disfunksiyasi (ChPBJD) bo‘lgan 40 nafar bemorda klinik-nevrologik simptomokompleksning xususiyatlari, vegetativ va psixoemotsional buzilishlarning o‘zaro bog‘liqligi hamda nevrologik yondashuvga asoslangan kompleks terapiya samaradorligi o‘rganildi. Barcha bemorlar nevrolog tomonidan batafsil nevrologik, vegetativ va psixometrik tekshiruvdan o‘tkazildi. Tadqiqot natijalari shuni ko‘rsatdiki, ChPBJDda yetakchi nevrologik sindromlar sifatida kuchlanish tipidagi bosh og‘rig‘i (95%), bosh aylanishi (70%), yuz sohasidagi paresteziyalar (55%) va vegetativ disfunksiya sindromi (90%) namoyon bo‘ladi. Og‘riq intensivligi bilan xavotir (r=0,72) va depressiya (r=0,65) darajalari o‘rtasida kuchli ijobiy korrelyatsion bog‘liqlik aniqlandi. Ishlab chiqilgan differensial nevrologik terapiya algoritmi (neyrometabolik vositalar, vegetativ korreksiya, kognitiv-xulqiy terapiya va postizometrik relaksatsiya) faqat stomatologik davo olgan nazorat guruhiga nisbatan statistik jihatdan ishonchli yuqori samaradorlikni ko‘rsatdi: og‘riq sindromi 2,1 ballga kamaydi (p<0,001), xavotir darajasi 32% ga pasaydi (p<0,01) va vegetativ muvozanat tiklandi.
Библиографические ссылки
De Leeuw R., Klasser G.D. Orofacial Pain: Guidelines for Assessment, Diagnosis, and Management. 7th ed. Chicago: Quintessence Publishing; 2023.
Okeson J.P. Management of Temporomandibular Disorders and Occlusion. 8th ed. St. Louis: Mosby; 2020.
Yakhno N.N., Parfenov V.A. Tension-type headache. Meditsinskiy sovet. 2022; (2): 42–48. (In Russian)
Schiffman E., Ohrbach R., Truelove E. et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). J Oral Facial Pain Headache. 2014; 28(1): 6–27.
Woolf C.J. Central sensitization: Implications for the diagnosis and treatment of pain. Pain. 2011; 152(3 Suppl): 2–15.
Chichorro J.G., Porreca F., Sessle B. Mechanisms of craniofacial pain. Cephalalgia. 2017; 37(7): 613–626.
Reiter S., Eli I., Gavish A., Winocur E. Ethnic differences in psychobehavioral factors in TMD patients. J Orofac Pain. 2006; 20(3): 226–234.
List T., Jensen R.H. Temporomandibular disorders: Old ideas and new concepts. Cephalalgia. 2017; 37(7): 692–704.
Pain syndromes in neurological practice / Ed. A.M. Vein. Moscow: MEDpress; 2001. (In Russian)
Slade G.D., Ohrbach R., Greenspan J.D. et al. Painful Temporomandibular Disorder. J Dent Res. 2016; 95(10): 1084–1092.
Vernon L.F. Craniocervical dysfunction and its relationship to temporomandibular disorders. Cranio. 2019; 37(1): 1–2.
Voronina T.A., Seredenin S.B. Nootropic and neuroprotective agents. Eksperim. i klinich. farmakologiya. 2021; 84(3): 3–11. (In Russian)
Cuciureanu M.D., Vink R. Magnesium and stress. In: Vink R., Nechifor M., editors. Magnesium in the Central Nervous System. Adelaide: University of Adelaide Press; 2011.
Turner J.A., Mancl L., Aaron L.A. Brief cognitive-behavioral therapy for temporomandibular disorder pain: Effects on daily electronic outcome and process measures. Pain. 2005; 117(3): 377–387.
Goldstein D.S. Adrenal responses to stress. Cell Mol Neurobiol. 2021; 41(6): 1097–1111.
